Autolus Therapeutics plc Income Statement

Income Statement Sep2016 Sep2017 Dec2017 Sep2018 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.21M1.69M0.03M1.41M0.02M2.91M1.47M1.51M6.19M1.70M10.12M
Gross Profit 1.21M1.69M0.03M1.41M0.02M-4.93M-9.33M1.51M6.19M1.70M-1.27M
Expense - Real Estate 7.84M10.80M
Operating items
Amortization - Intangibles 0.05M0.10M0.09M
Research & Development 10.44M16.01M-12.85M36.15M-32.90M105.42M134.89M110.84M117.35M130.48M138.44M
Wages, Salaries and Other 2611.00M3.00M
Share-based Compensation (IS) 3.15M2.49M3.65M6.71M33.31M19.36M10.69M
Selling, General & Administrative 5.15M9.10M-7.16M22.79M-22.50M39.45M34.97M31.86M31.90M46.74M101.09M
Other Operating Expenses -1.21M-1.69M-1.41M-331.37M0.00M-0.68M-0.52M-3.79M-0.22M
Operating Expenses 14.38M23.42M-20.02M57.53M-55.40M-186.50M-215.92M142.70M149.25M181.40M251.55M
Operating Income -23.42M-18.48M-57.53M-54.01M-146.06M-168.15M-141.05M-143.41M-179.70M-241.43M
EBIT -20.42M-23.42M-18.48M-57.53M-54.01M-146.06M-168.15M-141.05M-143.41M-179.70M-241.43M
Non-operating items
Interest & Investment Income 0.11M0.11M0.07M2.06M5.51M3.25M0.69M0.26M1.71M13.51M32.35M
Other Non Operating Income -0.04M-0.06M5.34M5.76M1.74M-0.14M2.04M2.64M-1.00M
Non Operating Income 0.05M-0.05M5.50M7.06M1.89M-0.99M-5.16M-28.70M22.29M
Net income details
EBT -20.42M-29.62M-18.39M-70.04M-48.48M-177.49M-213.50M-142.04M-148.57M-208.40M-219.13M
Tax Provisions -1.78M-3.70M-7.30M-15.20M-24.20M0.10M0.30M-0.02M1.53M
Profit After Tax -12.60M-19.73M-18.39M-44.75M-48.48M-123.85M-142.10M-142.10M-148.84M-208.40M-220.70M
Income from Continuing Operations -18.64M-25.92M-18.39M-62.74M-48.48M-162.29M-189.30M-142.14M-148.87M-208.38M-220.66M
Consolidated Net Income -18.64M-25.92M-18.39M-62.74M-48.48M-162.29M-189.30M-142.14M-148.87M-208.38M-220.66M
Income towards Parent Company -18.64M-25.92M-18.39M-62.74M-48.48M-162.29M-189.30M-142.14M-148.87M-208.38M-220.66M
Net Income towards Common Stockholders -18.64M-25.92M-18.39M-62.74M-48.48M-162.29M-189.30M-142.14M-148.87M-208.38M-220.66M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 37.78M37.78M40.15M44.98M52.30M72.92M91.13M265.93M266.12M
Shares Outstanding (Diluted Average) 173.94M255.16M
EBITDA -15.49M-18.93M-18.48M-50.82M-54.01M-117.05M-139.26M-144.81M-179.17M-198.48M-220.84M
Shares Outstanding 0.03M0.03M
Tax Rate 0.00M0.00M0.00M0.00M0.00M0.00M